As of Aug 30
| -0.0148 / -3.47%|
The 3 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 1.00, with a high estimate of 2.00 and a low estimate of 0.40. The median estimate represents a +143.01% increase from the last price of 0.41.
The current consensus among 4 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.